2024 Q2 Form 10-Q Financial Statement
#000086827824000007 Filed on May 10, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| Revenue | $2.474M | $3.634M | $4.351M |
| YoY Change | -81.28% | -81.17% | -80.06% |
| Cost Of Revenue | $2.950M | $4.067M | $7.407M |
| YoY Change | -56.42% | -53.69% | -29.72% |
| Gross Profit | -$476.0K | -$433.0K | -$3.056M |
| YoY Change | -107.38% | -104.12% | -127.08% |
| Gross Profit Margin | -19.24% | -11.92% | -70.24% |
| Selling, General & Admin | $7.212M | $7.593M | $8.022M |
| YoY Change | -27.42% | -8.5% | -37.04% |
| % of Gross Profit | |||
| Research & Development | $139.0K | $272.0K | $274.0K |
| YoY Change | -75.7% | 88.89% | -42.68% |
| % of Gross Profit | |||
| Depreciation & Amortization | $1.617M | $1.686M | $1.842M |
| YoY Change | 20.04% | 30.5% | 98.92% |
| % of Gross Profit | |||
| Operating Expenses | $7.351M | $7.865M | $8.296M |
| YoY Change | -33.81% | -18.46% | -49.33% |
| Operating Profit | -$7.827M | -$8.298M | -$11.35M |
| YoY Change | 68.03% | -1048.34% | 123.03% |
| Interest Expense | -$643.0K | $515.0K | -$455.0K |
| YoY Change | -320.96% | 139.53% | 359.6% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $30.00K | -$18.00K | $142.0K |
| YoY Change | 275.0% | -83.18% | |
| Pretax Income | -$8.440M | -$8.831M | -$11.67M |
| YoY Change | 71.75% | -1665.78% | 124.8% |
| Income Tax | -$2.287M | -$2.566M | -$2.914M |
| % Of Pretax Income | |||
| Net Earnings | -$6.153M | -$6.265M | -$8.751M |
| YoY Change | 78.87% | -1239.09% | 258.06% |
| Net Earnings / Revenue | -248.71% | -172.4% | -201.13% |
| Basic Earnings Per Share | -$0.33 | -$0.35 | |
| Diluted Earnings Per Share | -$0.33 | -$0.35 | -$0.48 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 19.08M shares | 18.05M shares | 18.05M shares |
| Diluted Shares Outstanding | 18.89M shares | 18.05M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.781M | $1.233M | $4.736M |
| YoY Change | -80.44% | -92.08% | -72.84% |
| Cash & Equivalents | $1.780M | $1.175M | $1.609M |
| Short-Term Investments | $1.000K | $58.00K | $3.127M |
| Other Short-Term Assets | $5.558M | $4.938M | $2.695M |
| YoY Change | 51.57% | 38.2% | 13.91% |
| Inventory | $3.867M | $3.758M | $3.841M |
| Prepaid Expenses | |||
| Receivables | $32.94M | $35.12M | $36.31M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $44.14M | $45.05M | $47.59M |
| YoY Change | -19.69% | -26.49% | -21.78% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $19.77M | $17.26M | $17.47M |
| YoY Change | 123.87% | 94.12% | 139.71% |
| Goodwill | $5.231M | $5.231M | $5.231M |
| YoY Change | 0.0% | 0.0% | -8.37% |
| Intangibles | $11.04M | $11.69M | $12.33M |
| YoY Change | -19.81% | -19.53% | 45.52% |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $860.0K | $316.0K | $9.308M |
| YoY Change | -26.05% | -72.83% | 700.34% |
| Total Long-Term Assets | $49.54M | $44.99M | $44.34M |
| YoY Change | 37.25% | 31.95% | 65.36% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $44.14M | $45.05M | $47.59M |
| Total Long-Term Assets | $49.54M | $44.99M | $44.34M |
| Total Assets | $93.68M | $90.03M | $91.93M |
| YoY Change | 2.88% | -5.6% | 4.88% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $13.63M | $11.76M | $9.383M |
| YoY Change | 184.75% | 141.66% | 58.9% |
| Accrued Expenses | $1.203M | $1.235M | $1.291M |
| YoY Change | -21.22% | 53.99% | 80.81% |
| Deferred Revenue | $1.821M | $1.630M | $2.382M |
| YoY Change | |||
| Short-Term Debt | $3.259M | $2.381M | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $3.897M | $1.840M | $1.840M |
| YoY Change | 970.6% | ||
| Total Short-Term Liabilities | $28.01M | $23.91M | $20.86M |
| YoY Change | 104.84% | 29.46% | 29.75% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $7.290M | $6.668M | $7.016M |
| YoY Change | 108.88% | 177.83% | 192.33% |
| Other Long-Term Liabilities | $14.30M | $14.59M | $14.67M |
| YoY Change | -2.3% | 0.16% | 175.87% |
| Total Long-Term Liabilities | $21.59M | $21.26M | $21.69M |
| YoY Change | 19.11% | 25.3% | 173.07% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $28.01M | $23.91M | $20.86M |
| Total Long-Term Liabilities | $21.59M | $21.26M | $21.69M |
| Total Liabilities | $49.60M | $45.17M | $42.54M |
| YoY Change | 55.98% | 27.47% | 77.14% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$17.45M | -$11.29M | -$5.029M |
| YoY Change | -296.85% | -191.8% | -142.79% |
| Common Stock | $18.00K | $18.00K | $18.00K |
| YoY Change | 5.88% | 5.88% | 12.5% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $44.08M | $44.87M | $49.38M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $93.68M | $90.03M | $91.93M |
| YoY Change | 2.88% | -5.6% | 4.88% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$6.153M | -$6.265M | -$8.751M |
| YoY Change | 78.87% | -1239.09% | 258.06% |
| Depreciation, Depletion And Amortization | $1.617M | $1.686M | $1.842M |
| YoY Change | 20.04% | 30.5% | 98.92% |
| Cash From Operating Activities | -$4.818M | -$5.119M | -$213.0K |
| YoY Change | -30.75% | -1175.42% | -126.26% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $26.00K | $939.0K | $1.310M |
| YoY Change | -101.16% | -72.55% | -17.92% |
| Acquisitions | $0.00 | ||
| YoY Change | -100.0% | ||
| Other Investing Activities | $150.0K | $3.374M | $46.00K |
| YoY Change | -114.58% | 90.73% | -101.35% |
| Cash From Investing Activities | $124.0K | $2.435M | -$1.264M |
| YoY Change | -89.79% | -247.4% | -74.74% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 5.323M | $2.271M | 2.924M |
| YoY Change | -11425.53% | 35.18% | -130.79% |
| NET CHANGE | |||
| Cash From Operating Activities | -4.818M | -$5.119M | -213.0K |
| Cash From Investing Activities | 124.0K | $2.435M | -1.264M |
| Cash From Financing Activities | 5.323M | $2.271M | 2.924M |
| Net Change In Cash | 629.0K | -$413.0K | 1.447M |
| YoY Change | -110.87% | -181.94% | -110.57% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.818M | -$5.119M | -$213.0K |
| Capital Expenditures | $26.00K | $939.0K | $1.310M |
| Free Cash Flow | -$4.844M | -$6.058M | -$1.523M |
| YoY Change | 2.78% | 105.7% | 94.01% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
-433000 | usd |
| CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
10520000 | usd |
| CY2024Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
0 | usd |
| CY2023Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
1203000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6265000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | |
| CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4067000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8783000 | usd |
| CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7593000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8298000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
272000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
144000 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
7865000 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
9645000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8298000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
875000 | usd |
| CY2024Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
0 | usd |
| CY2023Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
11000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
515000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
215000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-18000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-107000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-8831000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
564000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-2566000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
550000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
550000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
160000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-665000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6105000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-115000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.35 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.35 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18045000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16748000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
18045000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
18061000 | shares |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49383000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
160000 | usd |
| CY2024Q1 | prph |
Prepaid Share Based Compensation Expense
PrepaidShareBasedCompensationExpense
|
910000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1589000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44867000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
63631000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
541000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
398000 | usd |
| CY2023Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
5379000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-665000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
947000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
550000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59941000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
550000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
-18000 | usd |
| CY2023Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
-107000 | usd |
| CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1686000 | usd |
| CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1292000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
146000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
20000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
110000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
85000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1589000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
947000 | usd |
| CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
| CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-147000 | usd |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
0 | usd |
| CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
230000 | usd |
| CY2024Q1 | prph |
Inventory Valuation Reserve
InventoryValuationReserve
|
-69000 | usd |
| CY2023Q1 | prph |
Inventory Valuation Reserve
InventoryValuationReserve
|
1000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1197000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
864000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-152000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
336000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2122000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2107000 | usd |
| CY2024Q1 | prph |
Increase Decrease In Deferred Income Tax Assets
IncreaseDecreaseInDeferredIncomeTaxAssets
|
2612000 | usd |
| CY2023Q1 | prph |
Increase Decrease In Deferred Income Tax Assets
IncreaseDecreaseInDeferredIncomeTaxAssets
|
96000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-847000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2376000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2661000 | usd |
| CY2024Q1 | prph |
Increase Decrease In Accrued Diagnostic Services
IncreaseDecreaseInAccruedDiagnosticServices
|
-46000 | usd |
| CY2023Q1 | prph |
Increase Decrease In Accrued Diagnostic Services
IncreaseDecreaseInAccruedDiagnosticServices
|
-656000 | usd |
| CY2024Q1 | prph |
Increase Decrease In Accrued Advertising And Other Allowances
IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances
|
-16000 | usd |
| CY2023Q1 | prph |
Increase Decrease In Accrued Advertising And Other Allowances
IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances
|
52000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-752000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
443000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-459000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-80000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-273000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-341000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-626000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
4037000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5119000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
476000 | usd |
| CY2024Q1 | us-gaap |
Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
|
0 | usd |
| CY2023Q1 | us-gaap |
Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
|
478000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
2904000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
3374000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
1291000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
939000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
517000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2435000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1652000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
2460000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
7600000 | usd |
| CY2024Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
541000 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
5379000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
189000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2271000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1680000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-413000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
504000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2149000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9109000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1736000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9613000 | usd |
| CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
318000 | usd |
| CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1500000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
642000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
203000 | usd |
| CY2024Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | usd |
| CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1623000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued1
StockIssued1
|
0 | usd |
| CY2023Q1 | us-gaap |
Stock Issued1
StockIssued1
|
1000000 | usd |
| CY2022Q2 | prph |
Number Of Licensed Compounds
NumberOfLicensedCompounds
|
2 | numberoflicensedcompound |
| CY2022Q2 | prph |
Number Of Inhibitors
NumberOfInhibitors
|
2 | inhibitor |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and the accompanying notes thereto, in conformity with GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration of diagnostic test reimbursement rates, the allowance for credit losses and billing errors, allowances, slow moving and/or dated inventory and associated provisions, the potential impairment of long-lived assets, stock based compensation valuations, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the condensed consolidated financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div> | |
| CY2024Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
58000 | usd |
| CY2023Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
3127000 | usd |
| CY2023Q1 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P7Y | |
| CY2023Q1 | prph |
Asset Acquisition Transaction Costs
AssetAcquisitionTransactionCosts
|
200000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1600000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
|
500000 | usd |
| CY2023Q1 | prph |
Asset Acquisition Consideration Transferred Liability Payoff
AssetAcquisitionConsiderationTransferredLiabilityPayoff
|
1600000 | usd |
| CY2023Q1 | prph |
Asset Acquisition Consideration Transferred Promissory Note Payoff
AssetAcquisitionConsiderationTransferredPromissoryNotePayoff
|
400000 | usd |
| CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0005 | |
| CY2023Q1 | prph |
Asset Acquisition Shares Issued And Issuable Value Per Share
AssetAcquisitionSharesIssuedAndIssuableValuePerShare
|
10.00 | |
| CY2023Q1 | us-gaap |
Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
|
4600000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
|
500000 | usd |
| CY2023Q1 | prph |
Asset Acquisition Consideration Transferred Promissory Note Payoff
AssetAcquisitionConsiderationTransferredPromissoryNotePayoff
|
400000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
2000000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
2000000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
2000000 | usd |
| CY2023Q1 | us-gaap |
Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
2000000 | usd |
| CY2023Q1 | us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P6M | |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
19101000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
19101000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
7414000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
6768000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
11687000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
12333000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
646000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
754000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
1937000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
2583000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
2251000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1731000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
370000 | usd |
| CY2024Q1 | prph |
Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
|
2815000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
11687000 | usd |
| CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0005 | |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0005 | |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | usd |
| CY2023Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | usd |
| CY2023Q1 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
6000000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
900000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
8100000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P4Y | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2951000 | shares |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.30 | |
| CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y9M18D | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
693000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1790000 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.00 | |
| CY2024Q1 | prph |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
|
P7Y | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
289000 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
8.81 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4452000 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.68 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y7M6D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3012000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
2235000 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
6.43 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P4Y8M12D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
2290000 | usd |
| CY2024Q1 | us-gaap |
Share Price
SharePrice
|
6.47 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1790000 | shares |
| CY2024Q1 | prph |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
5300000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
6.00 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
6.84 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y6M | |
| CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y3M18D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.796 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.809 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.042 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.038 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.2866 | |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0040 | |
| CY2021Q2 | prph |
Manufacturing Agreement Renewal Options
ManufacturingAgreementRenewalOptions
|
4 | option |
| CY2021Q2 | prph |
Manufacturing Agreement Renewal Period
ManufacturingAgreementRenewalPeriod
|
P1Y | |
| CY2021Q2 | prph |
Agreement Term
AgreementTerm
|
P90D | |
| CY2022Q4 | prph |
Manufacturing Agreement Renewal Period
ManufacturingAgreementRenewalPeriod
|
P1Y | |
| CY2023Q1 | prph |
Number Of Sites
NumberOfSites
|
8 | investor |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5100000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5200000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4500000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4600000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
239000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
204000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
239000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
204000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
110000 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
0 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
180000 | usd |
| CY2023Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
0 | usd |
| CY2024Q1 | prph |
Finance Lease Cost
FinanceLeaseCost
|
290000 | usd |
| CY2023Q1 | prph |
Finance Lease Cost
FinanceLeaseCost
|
0 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
238000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
198000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P7Y2M12D | |
| CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P7Y4M24D | |
| CY2024Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y6M | |
| CY2023Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y9M18D | |
| CY2024Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1000 | |
| CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1000 | |
| CY2024Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.0756 | |
| CY2023Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.0756 | |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
5417000 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
5809000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
|
1200000 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
|
800000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
714000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1380000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid Remainder Of Fiscal Year
LeaseLiabilityToBePaidRemainderOfFiscalYear
|
2094000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
977000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
1840000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid Year One
LeaseLiabilityToBePaidYearOne
|
2817000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
941000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
1840000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid Year Two
LeaseLiabilityToBePaidYearTwo
|
2781000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
955000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
1188000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid Year Three
LeaseLiabilityToBePaidYearThree
|
2143000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
982000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
122000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid Year Four
LeaseLiabilityToBePaidYearFour
|
1104000 | usd |
| CY2024Q1 | prph |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
2667000 | usd |
| CY2024Q1 | prph |
Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
|
0 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid After Year Four
LeaseLiabilityToBePaidAfterYearFour
|
2667000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
7236000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
6370000 | usd |
| CY2024Q1 | prph |
Lease Liability To Be Paid
LeaseLiabilityToBePaid
|
13606000 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
2155000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
788000 | usd |
| CY2024Q1 | prph |
Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
|
2943000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5081000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
5582000 | usd |
| CY2024Q1 | prph |
Lease Liability
LeaseLiability
|
10663000 | usd |
| CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
3634000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
19303000 | usd |
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4067000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8783000 | usd |
| CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1605000 | usd |
| CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1237000 | usd |
| CY2024Q1 | prph |
Operating And Other Expenses
OperatingAndOtherExpenses
|
6793000 | usd |
| CY2023Q1 | prph |
Operating And Other Expenses
OperatingAndOtherExpenses
|
8719000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-8831000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
564000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-2566000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
550000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
550000 | usd |
| CY2024Q1 | us-gaap |
Assets
Assets
|
90032000 | usd |
| CY2023Q4 | us-gaap |
Assets
Assets
|
91927000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
550000 | usd |
| CY2024Q1 | prph |
Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
|
0 | usd |
| CY2023Q1 | prph |
Interest On Unsecured Convertible Promissory Note
InterestOnUnsecuredConvertiblePromissoryNote
|
60000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-6265000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
610000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18045000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
16748000 | shares |
| CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares |
| CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
240000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
18045000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
18061000 | shares |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4828000 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1451000 | shares |
